Overview

Multimodal Biomarkers for Diagnosis and Prognosis in VCI

Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
We will try to 1. establish the correlation of plasma Aβ40 and Aβ42 level, ApoE genotype, MRI imaging markers in the diagnosis and prognosis of VCI patients 2. understand more on the pathophysiology of VCI.
Phase:
Phase 3
Details
Lead Sponsor:
National Taiwan University Hospital